AP
GMAB icon

Americana Partners’s Genmab GMAB Stock Holding History

Americana Partners’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,841
Closed – – 258
2022
Q1 		$0 Buy
+17,841
New +$612K ﹤0.01% 251
2020
Q1 		– Sell
-1,018
Closed -$22K – 257
2019
Q4 		$22K Buy
+1,018
New +$22.2K 0.01% 342

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Americana Partners's GMAB Position: Q2 2022 in Review

Americana Partners sold out of Genmab (GMAB) in Q2 2022, closing a stake of 17,841 shares.

Americana Partners first reported a position in GMAB in Q4 2019 and held it in 2 quarters. The position peaked at $22K in Q4 2019. 180 funds tracked by Wall St. Rank hold GMAB as of Q2 2022.

  • Americana Partners reported no remaining Genmab position as of Q2 2022 after selling out during the quarter.
  • Americana Partners sold 17,841 Genmab shares in Q2 2022.
  • Americana Partners first reported a position in Genmab in Q4 2019 and held it in 2 quarters.
  • Americana Partners's Genmab position peaked at $22K in Q4 2019.
  • 180 funds tracked by Wall St. Rank held Genmab as of Q2 2022.

Based on Americana Partners's 13F filing for Q2 2022, filed 15 Aug 2022.